- Home
- DNN vs NMRA Comparison
DNN vs NMRA Comparison
Compare DNN & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNN
- NMRA
- Stock Information
- Founded
- DNN 1936
- NMRA 2019
- Country
- DNN Canada
- NMRA United States
- Employees
- DNN N/A
- NMRA N/A
- Industry
- DNN Other Metals and Minerals
- NMRA
- Sector
- DNN Basic Materials
- NMRA
- Exchange
- DNN Nasdaq
- NMRA Nasdaq
- Market Cap
- DNN 1.8B
- NMRA 1.7B
- IPO Year
- DNN 1997
- NMRA 2023
- Fundamental
- Price
- DNN $1.87
- NMRA $11.17
- Analyst Decision
- DNN Strong Buy
- NMRA Strong Buy
- Analyst Count
- DNN 2
- NMRA 5
- Target Price
- DNN $3.00
- NMRA $23.40
- AVG Volume (30 Days)
- DNN 19.7M
- NMRA 869.9K
- Earning Date
- DNN 11-07-2024
- NMRA 11-12-2024
- Dividend Yield
- DNN N/A
- NMRA N/A
- EPS Growth
- DNN N/A
- NMRA N/A
- EPS
- DNN N/A
- NMRA N/A
- Revenue
- DNN $2,920,167.00
- NMRA N/A
- Revenue This Year
- DNN $272.08
- NMRA N/A
- Revenue Next Year
- DNN $77.80
- NMRA N/A
- P/E Ratio
- DNN N/A
- NMRA N/A
- Revenue Growth
- DNN N/A
- NMRA N/A
- 52 Week Low
- DNN $1.40
- NMRA $8.33
- 52 Week High
- DNN $2.47
- NMRA $21.00
- Technical
- Relative Strength Index (RSI)
- DNN 36.18
- NMRA 57.51
- Support Level
- DNN $1.88
- NMRA $10.43
- Resistance Level
- DNN $1.96
- NMRA $11.37
- Average True Range (ATR)
- DNN 0.09
- NMRA 0.74
- MACD
- DNN -0.03
- NMRA 0.19
- Stochastic Oscillator
- DNN 5.32
- NMRA 92.26
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company with interests focused in the Athabasca Basin region of northern Saskatchewan, Canada. The company has an effective 95% interest in its flagship Wheeler River Uranium Project, which is the largest undeveloped uranium project in the infrastructure-rich eastern portion of the Athabasca Basin region of northern Saskatchewan. The company is also engaged in mine decommissioning and environmental services through its Closed Mines group, which manages its Elliot Lake reclamation projects and provides third-party post-closure mine care and maintenance services.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.